| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cleavage stimulation factor subunit 2 tau variant | 8.6E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||||
|
IZUMO family member 3 | 3.0E-11 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 1 | 2018 | 2018 | ||||||||||
|
CYP17A1 promoter |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||||
|
RAB, member of RAS oncogene family like 2A | 7.3E-08 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||||
|
serine protease 37 | 2.5E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||||
|
ribosomal protein L10 like | 5.2E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
testis specific serine kinase 1A, pseudogene |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||||
|
RBMX like 2 | 7.5E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
H1.7 linker histone |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||||
|
ornithine decarboxylase antizyme 3 | 2.3E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||||
|
epididymal peptidase inhibitor | 7.4E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 2 | 2010 | 2010 | ||||||||||
|
SPATA31 subfamily A member 1 | 0.38 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
tetratricopeptide repeat domain 29 | 1.3E-08 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.360 | None | 0.833 | 6 | 4 | 2007 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |